Is aluminum exposure a risk factor for neurological disorders?
- PMID: 30057635
- PMCID: PMC6040147
- DOI: 10.4103/jrms.JRMS_921_17
Is aluminum exposure a risk factor for neurological disorders?
Abstract
Aluminum (Al) is widely found in the nature. Although the relation between Al and neurodegenerative diseases is still controversial, Al is related with many brain diseases including Alzheimer's disease, Parkinson's disease, and multiple sclerosis. Al exposure occurs mainly through environment, occupational, and dietary factors for humans. Al exposure with diet can be through foods, food additives, water, and contamination of Al equipment/utensils. The aim of this review is to summarize various hypotheses, which link Al and neurodegeneration, and to determine the roles of Al exposure through different sources including diet, environment, and occupation. Future studies should be done in vulnerable subgroups of population including children, patients receiving antacid or Al-containing pharmeteucials on a daily basis, patients with reduced renal function, and patients on parenteral nutrition regimens that are likely to be affected by possible adverse health effects of Al. In addition, gender, age, and Al interactions need to be determined. One of the most important challanges in future epidemiological studies is to determine which variables should be controlled. In addition, experimental studies should be more focused and translational. In this context, exposure dose, dose-response effects, and time lapse between exposures and cognitive assessments are very important.
Keywords: Aluminum; Alzheimer's disease; Parkinson's disease; multiple sclerosis; neurodegenerative diseases.
Conflict of interest statement
There are no conflicts of interest.
Figures
References
-
- Domingo JL. Aluminium. In: Benjamin C, editor. Encyclopedia of Food Sciences and Nutrition. 2nd ed. Oxford: Academic Press; 2003. pp. 160–6.
-
- Aronson JK. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. 15th ed. Amsterdam: Elsevier; 2006. Aluminium; pp. 97–105.
-
- Vargel C. 1st ed. Oxford: Elseiver; 2004. Food Industry.
-
- Moore PB, Day JP, Taylor GA, Ferrier IN, Fifield LK, Edwardson JA, et al. Absorption of aluminium-26 in Alzheimer's disease, measured using accelerator mass spectrometry. Dement Geriatr Cogn Disord. 2000;11:66–9. - PubMed
-
- Wilhelm M, Jäger DE, Ohnesorge FK. Aluminium toxicokinetics. Pharmacol Toxicol. 1990;66:4–9. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
